All type of patients: 1 trials - TRACER
All type of patients: 1 trials - TRA-2P TIMI 50
Secondary prevention in patients with CAD: 1 trials - TRA-2P TIMI 50
Secondary prevention: 3 trials - TRA-2P TIMI 50 - TRA-2P TIMI 50 (MI subgroup) - TRA-2P TIMI 50 (no prior stroke sub group)
Secondary prevention in patients with intermittent claudication: 1 trials - TRA-2P TIMI 50